Table 1. RNA in glioblastoma microvesicles can be used as sensitive biomarkers.
Patient# | Time of serum collection* | Serum volume | Biopsy EGFRvIII | Serum exosome EGFRvIII |
---|---|---|---|---|
1 | 0 | 3 ml | Yes | Yes |
2 | 0 | 2 ml | No | No |
3 | 0 | 2.5 ml | No | No |
4 | 0 | 1 ml | Yes | No |
5 | 0 | 1 ml | Yes | No |
6 | 0 | 1 ml | No | No |
7 | 0 | 0.6 ml | Yes | Yes |
8 | 0 | 1 ml | No | No |
9 | 0 | 1 ml | Yes | Yes |
10 | 0 | 1 ml | No | Yes |
11 | 0 | 2 ml | Yes | No |
12 | 0 | 2 ml | Yes | Yes |
13 | 0 | 2 ml | No | Yes |
14 | 0 | 2 ml | Yes | Yes |
15 | 0 | 2 ml | No | No |
16 | 0 | 2 ml | No | No |
17 | 0 | 1 ml | Yes | No |
18 | 0 | 0.8 ml | Yes | No |
19 | 0 | 1 ml | No | No |
20 | 0 | 1 ml | No | No |
21 | 0 | 1 ml | No | No |
22 | 0 | 1 ml | No | No |
23 | 0 | 1 ml | No | No |
24 | 0 | 1 ml | No | No |
25 | 0 | 1 ml | No | No |
26 | 14 | 0.6 ml | Yes | No |
27 | 14 | 1.2 ml | No | No |
28 | 14 | 0.8 ml | Yes | No |
29 | 14 | 0.9 ml | Yes | No |
30 | 14 | 0.6 ml | Yes | No |
Days post-surgery